Cite
HARVARD Citation
Levêque, C. et al. (n.d.). A Phase III, Single-Center, Randomized Controlled Trial Comparing Clinical and Cost-Effectiveness Analyses of Botulinum Toxin Uterine Injections Versus Placebo for Severe Dysmenorrhea and Chronic Pelvic Pain of Uterine Origin After Standard Therapeutic Failure. Toxicon. pp. S35-. [Online].